Governance Data (up-to-date)
Corporate Governance
| Unit | CY2020.6 | CY2021.6 | CY2022.6 | CY2023.6 | CY2024.6 | ||
|---|---|---|---|---|---|---|---|
| Structure of Board of Directors | Directors | Persons | 6 | 6 | 8 | 7 | 8 |
| Outside directors | Persons | 3 | 3 | 5 | 5 | 4 | |
| Female directors | Persons | 1 | 1 | 2 | 2 | 2 | |
| Structure of Board of Corporate Auditors | Corporate Auditors | Persons | 4 | 4 | 4 | 4 | 4 |
| Outside Corporate Auditors | Persons | 3 | 3 | 3 | 3 | 3 | |
| Female Corporate Auditors | Persons | 1 | 1 | 1 | 1 | 1 | |
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | |||
| Meetings of the Board of Directors held | Times | 14 | 14 | 14 | 13 | 13 | |
| Meetings of the Board of Corporate Auditors held | Times | 10 | 10 | 10 | 11 | 10 | |
| Attendance rate for meetings of the Board of Directors (Members of the Board) | % | 100% | 100% | 100% | 100% | 98% | |
| Attendance rate for meetings of the Board of Directors (Members of the Board of Corporate Auditors) | % | 100% | 100% | 98% | 100% | 98% | |
| Attendance rate for the meetings of the Board of Corporate Auditors | % | 100% | 100% | 100% | 100% | 100% | |
| CEO compensation | Thousands of yen | - | - | - | - | 191,000 | |
| CEO-to-employee pay ratio(*) | Consolidated | Times | - | - | - | - | 18.3 |
- Please refere to Social data for average remuneration of employees
Compliance
| Scope | Unit | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | |
|---|---|---|---|---|---|---|---|
| Annual compliance education | Consolidated | % | - | - | 98.8% | 95.5% | 99.9% |
| Major compliance violations | Consolidated | Cases | - | - | 0 | 0 | 0 |
| Consultation and reporting received | Consolidated | Cases | - | - | 45 | 35 | 45 |
| Corruption or Bribery | Consolidated | Cases | - | - | - | 0 | 1 |
| Discrimination or Harassment | Consolidated | Cases | - | - | - | 10 | 25 |
| Customer Privacy Data | Consolidated | Cases | - | - | - | 0 | 0 |
| Conflicts of Interest | Consolidated | Cases | - | - | - | 2 | 1 |
| Money Laundering or Insider trading | Consolidated | Cases | - | - | - | 0 | 0 |
| Others | Consolidated | Cases | - | - | - | 23 | 18 |
| Disciplinary actions taken | Consolidated | Cases | - | - | 2 | 6 | 16 |
| Legal actions for corruption received | Consolidated | Cases | 0 | 0 | 0 | 0 | 0 |
| Lawsuit filed due to legal violations | Consolidated | Cases | 0 | 0 | 0 | 0 | 0 |
| Breaches of client data reported to regulators | Consolidated | Cases | 0 | 0 | 0 | 0 | 0 |
| Regulatory complaints concerning marketing and selling practices | Consolidated | Cases | 0 | 0 | 0 | 0 | 1 |
Information Security
| Scope | Unit | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | |
|---|---|---|---|---|---|---|---|
| Information security breaches | Consolidated | Cases | - | 0 | 0 | 0 | 0 |
Policy Influence
| Scope | Unit | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | |
|---|---|---|---|---|---|---|---|
| Political contributions | Non-consolidated | Millions of yen | - | - | 4 | 4 | 4 |
| Industry and business association participation fees | Non-consolidated | Millions of yen | - | - | 50 | 40 | 50 |
| Lobbying | Non-consolidated | Millions of yen | - | - | 0 | 0 | 0 |
Revenues, Income Tax Paid, etc. by Country (*1)
| Country | Revenues | Profit(Loss) before Income Tax | Income Tax Paid (on Cash Basis) | Income Tax Accrued - Current Year | Number of employees |
|---|---|---|---|---|---|
| Japan | 202,963 | 27,246 | 8,154 | 9,059 | 1,929 |
| Switzerland | 70,248 | -19,041 | 50 | 68 | 176 |
| China | 27,887 | 407 | 1,866 | 298 | 725 |
| Finland | 19,479 | 530 | 131 | 116 | 190 |
| Singapore | 14,965 | 3,847 | 107 | -172 | 140 |
| South Korea | 12,581 | 1,876 | 289 | 375 | 88 |
| Other | 73,024 | -42,424 | 460 | 768 | 896 |
| Total | 421,147 | -27,560 | 11,057 | 10,512 | 4,144 |
- The above amounts are based on the statutory "Country-by-Country Report (CbCR)" and differ from the Consolidated Financial Statements. The amount of revenue includes not only operating revenue, but also financial income, dividends received, and gains on sales of securities/fixed assets.
Official SNS
